This site is intended for Healthcare professionals only.

Unichem Lab’s Ghaziabad unit gets EIR from USFDA


Unichem Lab’s Ghaziabad unit gets EIR from USFDA

New Delhi: Drug firm Unichem Laboratories said its facility at Ghaziabad has received establishment inspection report (EIR) from the US health regulator.

The inspection was conducted by United States Food and Drug Administration (USFDA) in April 2018, Unichem Laboratories said in a filing to BSE.

“Unichem’s formulation manufacturing facility at Ghaziabad has received an EIR from USFDA indicating closure of inspection,” it added.



Source: PTI
0 comment(s) on Unichem Lab’s Ghaziabad unit gets EIR from USFDA

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted